DCTH Delcath Systems, Inc. - Common Stock
$16,93
Prix · Aoû 18, 2026
Données fondamentales au Aoû 6, 2026
Fourchette 52 semaines
$8–$17
95% of range
Note des analystes
BUY
12 analysts
Objectif de cours
$24
+42% upside
P/E (TTM)
241.9
ROE
2.5%
Marge nette
3.2%
À propos de Delcath Systems, Inc. - Common Stock Présentation de l'entreprise depuis Wikipedia
Delcath Systems, Inc. is a publicly traded specialty pharmaceutical and medical device company, that develops percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to specific organs or regions of the body. Based in Queensbury, New York, the company has an intellectual property portfolio consisting of 28 patents worldwide. Delcath's Percutaneous Hepatic Perfusion (PHP) is currently undergoing Phase II and Phase III trials against tumors in the liver. Delcath has a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute and has received Fast Track and a Special Protocol Assessment from the Food and Drug Administration for its use of melphalan in treating unresectable liver tumors. PHP, also known as the Delcath System, is tested for the treatment of metastatic melanoma in the liver and for primary liver cancer and metastatic hepatic malignancies from neuroendocrine cancers and adenocarcinomas, as well as patients with melanoma who previously received isolated perfusion. Chemotherapy is usually delivered intravenously, although a number of agents can be administered orally.
Lire la suite
Delcath Systems, Inc. (NASDAQ: DCTH) is a publicly traded specialty pharmaceutical and medical device company, that develops percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to specific organs or regions of the body. Based in Queensbury, New York, the company has an intellectual property portfolio consisting of 28 patents worldwide. Delcath's Percutaneous Hepatic Perfusion (PHP) is currently undergoing Phase II and Phase III trials against tumors in the liver. Delcath has a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute and has received Fast Track and a Special Protocol Assessment from the Food and Drug Administration for its use of melphalan in treating unresectable liver tumors. PHP, also known as the Delcath System, is tested for the treatment of metastatic melanoma in the liver and for primary liver cancer and metastatic hepatic malignancies from neuroendocrine cancers and adenocarcinomas, as well as patients with melanoma who previously received isolated perfusion. Chemotherapy is usually delivered intravenously, although a number of agents can be administered orally (e.g. specialty drugs, melphalan (trade name Alkeran), busulfan, capecitabine).
## Phase III melanoma trial enrolling
University of Pittsburgh Medical Center
National Cancer Institute in Bethesda, Maryland
Albany Medical Center in Albany, New York
John Wayne Cancer Center in Santa Monica, California
Moffitt Cancer Center in Tampa, Florida
Morristown Memorial Hospital in Morristown, New Jersey
Providence Cancer Center in Portland, Oregon
St. Luke's Cancer Center of Bethlehem, Pennsylvania
Swedish Medical Center in Englewood, Colorado
University of Maryland Medical Center in Baltimore, Maryland
University of Texas Medical Branch in Galveston, Texas
Source : Wikipedia (Anglais), CC BY-SA 4.0 · Voir sur Wikipedia ↗
DCTH Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$16.93
Capitalisation Boursière
$587M
P/E (TTM)
241.9
BPA (TTM)
$0.07
Revenus (TTM)
$85M
Rendement div.
—
ROE
2.5%
Dette/Capitaux propres
—
Fourchette 52 semaines
$8 – $17
DCTH Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$85M
2016-12-31
→
2025-12-31
BPA
$0.07
2017-12-31
→
2025-12-31
Flux de trésorerie libre
$21M
2018-12-31
→
2025-12-31
Marges
3.2%
2022-12-31
→
2025-12-31
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
DCTH
Médiane des pairs
P/E (TTM)
241.9
32.9
P/S (TTM)
6.9
4.6
P/B
5.3
3.5
Price / FCF (Cours / FCF)
28.0
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
DCTH
Médiane des pairs
Gross Margin (Marge Brute)
86.2%
66.5%
Operating Margin (Marge d'exploitation)
0.77%
—
Net Profit Margin (Marge nette)
3.2%
-9.8%
ROA
2.7%
-8.8%
ROE
2.5%
-15.5%
ROIC
0.46%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
DCTH
Médiane des pairs
Current Ratio (Ratio de liquidité)
10.9
4.8
Quick Ratio (Ratio de liquidité réduite)
5.0
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
DCTH
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
129.1%
—
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
215.3%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
DCTH
Médiane des pairs
DCTH Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
12 analystes
- Achat fort 3 25,0%
- Achat 8 66,7%
- Conserver 1 8,3%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
5 analystes · 2026-08-18
Médiane
$22.00
Moyenne
$24.00
← En dessous de tous les objectifs
$16.93
Bas
$21.00
Haut
$32.00
Objectif médian
$22.00
+29,9%
Objectif moyen
$24.00
+41,8%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.05%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 30 juin 2026 | $0.07 | $-0.09 | 0.16% |
| 31 mars 2026 | $-0.03 | $-0.09 | 0.06% |
| 31 décembre 2025 | $-0.05 | $-0.06 | 0.01% |
| 30 septembre 2025 | $0.02 | $0.02 | -0.00% |
| 30 juin 2025 | $0.07 | $0.03 | 0.04% |
| 31 mars 2025 | $0.03 | $0.02 | 0.01% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| DCTH | $350M | 144.3 | 129.1% | 3.2% | 2.5% | 86.2% |
| BBNX | $1.35B | -16.8 | 53.9% | -73.0% | -24.9% | 55.4% |
| SSII | — | -94.7 | 105.7% | — | — | — |
| ANGO | $479M | -13.0 | 9.5% | -11.5% | -21.2% | 54.6% |
| TCMD | $651M | 35.4 | 12.5% | 5.8% | 9.2% | 75.9% |
| NPCE | $518M | -23.4 | 25.1% | -21.5% | -111.6% | 77.2% |
| VREX | $498M | -7.0 | 4.1% | -8.3% | -14.0% | 34.4% |
| CLPT | $402M | -15.2 | 17.8% | -69.1% | -106.9% | 61.4% |
| SGHT | $424M | -10.7 | -3.1% | -49.7% | -57.4% | 86.2% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 18
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $85M | $37M | $2M | $3M | $4M | · | · | · | $3M | $2M | $2M | $1M | |
| Cost of Revenue | $12M | $6M | $635.0K | $686.0K | $671.0K | $640.0K | $719.0K | $1M | $701.0K | $550.0K | $462.0K | $291.0K | |
| Gross Profit | $73M | $31M | $1M | $2M | $3M | $1M | $861.0K | $2M | $2M | $1M | $1M | $778.0K | |
| R&D Expense | $29M | $14M | $18M | $19M | $14M | $11M | $9M | $20M | $10M | $8M | $6M | $4M | |
| SG&A Expense | $44M | $30M | $22M | $17M | $14M | $11M | $11M | $10M | $10M | $9M | $10M | $16M | |
| Operating Expenses | $73M | $43M | $40M | $36M | $27M | $22M | $21M | $29M | $20M | $18M | $16M | $20M | |
| Operating Income | $660.0K | $-12M | $-38M | $-34M | $-25M | $-21M | $-20M | $-27M | $-18M | $-16M | $-15M | $-19M | |
| Interest Expense | · | · | · | · | · | · | · | · | $22M | $14M | $67.0K | · | |
| Interest Income | · | · | · | · | · | · | · | · | · | $17.0K | $9.0K | $5.0K | |
| Other Non-op | $-70.0K | $-30.0K | $-59.0K | $30.0K | $68.0K | $154.0K | $2.0K | $51.0K | $-41.0K | $17.0K | $9.0K | $-24.0K | |
| Pretax Income | $4M | $-26M | $-48M | $-37M | $-26M | $-24M | $-9M | $-19M | $-45M | $-18M | $-15M | $-17M | |
| Income Tax | $810.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $3M | $-26M | $-48M | $-37M | $-26M | $-24M | $-9M | $-19M | $-45M | $-18M | $-15M | $-17M | |
| EPS (Basic) | $0.08 | $-0.93 | $-2.94 | $-4.12 | $-3.59 | $-8.35 | $-342.83 | $-0.72 | $-3250.00 | · | $-0.91 | $-1.84 | |
| EPS (Diluted) | $0.07 | $-0.93 | $-2.94 | $-4.12 | $-3.59 | $-8.35 | $-342.83 | $-0.72 | $-3250.00 | · | $-0.91 | $-1.84 | |
| Shares (Basic) | 35,821,157 | 28,511,393 | 16,229,931 | 8,864,615 | 7,145,754 | 2,897,827 | 25,900 | 26,705,375 | 14,039 | · | 16,161,687 | 9,452,050 | |
| Shares (Diluted) | 39,919,557 | 28,511,393 | 16,229,931 | 8,864,615 | 7,145,754 | 2,897,827 | 25,900 | 26,705,375 | 14,039 | · | 16,161,687 | 9,452,050 | |
| EBITDA | $660.0K | $-12M | $-38M | $-34M | $-25M | $-21M | $-20M | $-27M | · | · | $-15M | $-19M |
Bilan 25
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $43M | $32M | $13M | $8M | $23M | $29M | $10M | $3M | $4M | $4M | $13M | $20M | |
| Receivables | $12M | $11M | $241.0K | $366.0K | $44.0K | $57.0K | $21.0K | $585.0K | $317.0K | $403.0K | $277.0K | $174.0K | |
| Inventory | $10M | $7M | $3M | $2M | $1M | $855.0K | $654.0K | $858.0K | $1M | $660.0K | $757.0K | $349.0K | |
| Prepaid Expense | $6M | $3M | $1M | $2M | $3M | $3M | $2M | $898.0K | $700.0K | $698.0K | $960.0K | $974.0K | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $222.0K | |
| Current Assets | $120M | $74M | $37M | $16M | $31M | $32M | $13M | $6M | $8M | $34M | $15M | $22M | |
| PP&E (Net) | $3M | $2M | $1M | $1M | $1M | $1M | $735.0K | $925.0K | $1M | $1M | $1M | $2M | |
| PP&E (Gross) | $8M | $7M | $6M | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $6M | |
| Accum. Depreciation | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | |
| Total Assets | $124M | $77M | $39M | $18M | $33M | $35M | $14M | $7M | $9M | $35M | $16M | $24M | |
| Accounts Payable | $3M | $961.0K | $1M | $2M | $638.0K | $2M | $5M | $8M | $4M | $594.0K | $284.0K | $748.0K | |
| Accrued Liabilities | $8M | $5M | $5M | $5M | $4M | $5M | $7M | $8M | $3M | $3M | $2M | $4M | |
| Current Liabilities | $11M | $6M | $16M | $15M | $6M | $10M | $16M | $18M | $8M | $36M | $6M | $5M | |
| Capital Leases | $835.0K | $933.0K | $0 | · | $207.0K | $450.0K | $197.0K | $0 | · | · | · | · | |
| Other Non-current Liabilities | $628.0K | $766.0K | $840.0K | $1M | $207.0K | · | $0 | $628.0K | $395.0K | $604.0K | $820.0K | $1M | |
| Total Liabilities | $12M | $8M | $23M | $24M | $21M | $13M | $21M | $22M | $8M | $37M | $7M | $6M | |
| Long-term Debt | · | $0 | $10M | $16M | · | · | · | · | · | · | · | · | |
| Common Stock | $347.0K | $331.0K | $228.0K | $100.0K | $79.0K | $60.0K | $1.0K | $0 | $2.0K | $0 | $14.0K | $97.0K | |
| Paid-in Capital | $639M | $600M | $521M | $452M | $433M | $417M | $365M | $329M | $326M | $278M | $270M | $265M | |
| Retained Earnings | $-529M | $-532M | $-505M | $-457M | $-421M | $-395M | $-371M | $-344M | $-325M | $-279M | $-261M | $-247M | |
| Treasury Stock | · | · | · | · | · | · | · | $0 | $51.0K | $51.0K | $51.0K | $51.0K | |
| AOCI | $575.0K | $82.0K | $135.0K | $-83.0K | $18.0K | $-104.0K | $28.0K | $50.0K | $42.0K | $-41.0K | $-8.0K | $20.0K | |
| Stockholders' Equity | $111M | $69M | $16M | $-6M | $12M | $22M | $-6M | $-15M | $678.0K | $-1M | $9M | $18M | |
| Liabilities + Equity | $124M | $77M | $39M | $18M | $33M | $35M | $14M | $7M | $9M | $35M | $16M | $24M | |
| Shares Outstanding | 34,691,671 | 33,061,002 | 22,761,554 | 10,046,571 | 7,906,728 | 5,996,101 | 67,091 | 14,715 | 228,139 | 11,750 | 1,360,239 | 9,708,841 |
Flux de trésorerie 12
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Deferred Tax | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $23M | $-19M | $-31M | $-25M | $-23M | $-23M | $-24M | $-15M | $-15M | $-14M | $-16M | $-16M | |
| CapEx | $2M | $559.0K | $58.0K | $209.0K | $143.0K | $782.0K | $24.0K | $76.0K | $524.0K | $258.0K | $170.0K | $44.0K | |
| Investing Cash Flow | $-27M | $-981.0K | $-20M | $-209.0K | $-143.0K | $-782.0K | $-24.0K | $-76.0K | $-524.0K | · | · | · | |
| Net Debt Issued | · | $-11M | $-6M | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $481.0K | $250.0K | $123.0K | $0 | $2M | $230.0K | $0 | $11M | · | · | · | · | |
| Stock Repurchased | $6M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $-6M | $250.0K | $123.0K | · | $2M | $230.0K | $0 | · | · | · | · | · | |
| Financing Cash Flow | $15M | $39M | $52M | $10M | $21M | $42M | $30M | $13M | $-11M | · | · | · | |
| Net Change in Cash | $11M | $20M | $874.0K | $-15M | $-2M | $19M | $7M | $-2M | $-26M | $-8M | $-8M | $-11M | |
| Taxes Paid | $2M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $21M | $-19M | $-31M | $-25M | $-23M | $-24M | $-24M | $-15M | · | · | $-17M | $-16M |
Rentabilité 8
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 86.2% | 83.4% | 69.2% | 74.8% | · | · | · | · | · | · | 73.6% | 72.8% | |
| Operating Margin | 0.77% | -33.4% | -1849.0% | -1245.0% | · | · | · | · | · | · | -870.6% | -1805.8% | |
| Net Margin | 3.2% | -70.9% | -2308.9% | -1342.7% | · | · | · | · | · | · | -841.7% | -1625.9% | |
| Pretax Margin | 4.1% | -70.9% | -2308.9% | -1342.7% | · | · | · | · | · | · | -841.7% | · | |
| EBITDA Margin | 0.77% | -33.4% | -1849.0% | -1245.0% | · | · | · | · | · | · | -870.6% | -1805.8% | |
| ROA | 2.7% | -45.8% | -168.8% | -143.2% | -75.7% | -98.9% | -84.3% | -244.4% | · | · | -74.5% | -57.1% | |
| ROE | 2.5% | -68.2% | -235.5% | 657.5% | -216.7% | -190.6% | 70.5% | 194.1% | · | · | -109.9% | -72.0% | |
| ROIC | 0.46% | -18.1% | -242.0% | 577.8% | -205.3% | -96.5% | 313.2% | · | · | · | -176.8% | · |
Liquidité et Solvabilité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.9 | 12.0 | 2.3 | 1.1 | 5.2 | 3.2 | 0.8 | 0.3 | · | · | 2.3 | 4.8 | |
| Quick Ratio | 5.0 | 7.0 | 0.8 | 0.5 | 3.8 | 2.9 | 0.6 | 0.2 | · | · | 2.0 | 4.5 |
Efficacité 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.9 | 0.6 | 0.1 | 0.1 | · | · | · | · | · | · | 0.1 | 0.0 | |
| Inventory Turnover | 1.4 | 1.2 | 0.2 | 0.4 | 0.6 | 0.8 | 1.0 | 1.0 | · | · | 0.8 | 0.5 | |
| Receivables Turnover | 7.5 | 6.7 | 6.8 | 13.3 | · | · | · | · | · | · | 7.7 | 4.1 |
Taux de croissance 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 129.1% | 1701.7% | -24.1% | -23.5% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 215.3% | 118.7% | · | · | · | · | · | · | · | · | · | · |
Valorisation (TTM) 10
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $85M | $37M | $2M | $3M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | |
| Net Income TTM | $3M | $-26M | $-48M | $-37M | $-26M | $-24M | $-9M | $-19M | $-45M | $-18M | $-15M | $-17M | |
| Market Cap | $350M | $398M | $95M | $28M | $61M | $107M | $1M | $2.01B | · | · | · | · | |
| P/E | 144.3 | -12.9 | -1.4 | -0.9 | -2.2 | -2.1 | -0.1 | -272.2 | · | · | · | · | |
| P/S | 4.1 | 10.7 | 45.9 | 10.5 | 17.2 | 34.8 | 0.5 | 649.3 | · | · | · | · | |
| P/B | 3.2 | 5.8 | 6.0 | -4.9 | 5.1 | 4.9 | -0.2 | -134.2 | · | · | · | · | |
| P / Tangible Book | 3.2 | 5.8 | 6.0 | · | 5.1 | 4.9 | · | · | · | · | · | · | |
| P / Cash Flow | 15.6 | -21.3 | -3.0 | -1.1 | -2.7 | -4.7 | -0.1 | -136.1 | · | · | · | · | |
| P / FCF | 16.7 | -20.7 | -3.0 | -1.1 | -2.7 | -4.5 | -0.1 | -135.4 | · | · | · | · | |
| Earnings Yield | 0.69% | -7.7% | -70.7% | -114.4% | -46.3% | -46.6% | -1613.3% | -0.37% | · | · | · | · |
Compte de résultat 16
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $29M | $25M | $21M | $21M | $24M | $20M | $15M | $11M | $8M | $3M | $539.0K | $434.0K | $495.0K | $597.0K | $638.0K | $906.0K | |
| Cost of Revenue | $3M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $903.0K | $171.0K | $133.0K | $150.0K | $181.0K | $238.0K | $235.0K | |
| Gross Profit | $26M | $21M | $18M | $18M | $21M | $17M | $13M | $10M | $6M | $2M | $368.0K | $301.0K | $345.0K | $416.0K | $400.0K | $671.0K | |
| R&D Expense | $10M | $10M | $9M | $8M | $7M | $5M | $3M | $4M | $3M | $4M | $5M | $5M | $4M | $5M | $4M | $4M | |
| SG&A Expense | $13M | $13M | $11M | $10M | $11M | $11M | $7M | $7M | $7M | $9M | $7M | $6M | $5M | $4M | $4M | $5M | |
| Operating Expenses | $24M | $23M | $20M | $18M | $18M | $16M | $10M | $11M | $10M | $13M | $12M | $11M | $8M | $9M | $8M | $9M | |
| Operating Income | $2M | $-2M | $-2M | $-388.0K | $3M | $642.0K | $3M | $-1M | $-4M | $-10M | $-11M | $-11M | $-8M | $-8M | $-8M | $-8M | |
| Other Non-op | $-17.0K | $-58.0K | $-7.0K | $-33.0K | $-34.0K | $4.0K | $-53.0K | $35.0K | $10.0K | $-22.0K | $-73.0K | $-5.0K | $6.0K | $13.0K | $27.0K | $26.0K | |
| Pretax Income | $3M | $-908.0K | $-1M | $375.0K | $3M | $1M | $-3M | $2M | $-14M | $-11M | · | · | · | · | · | · | |
| Income Tax | $491.0K | $162.0K | $562.0K | $-455.0K | $508.0K | $195.0K | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Income | $3M | $-1M | $-2M | $830.0K | $3M | $1M | $-3M | $2M | $-14M | $-11M | $-11M | $-20M | $-7M | $-9M | $-8M | $-9M | |
| EPS (Basic) | $0.07 | $-0.03 | $-0.05 | $0.02 | $0.08 | $0.03 | $-0.06 | $0.06 | $-0.48 | $-0.45 | $-0.45 | $-1.14 | $-0.58 | $-0.77 | $-0.82 | $-0.96 | |
| EPS (Diluted) | $0.07 | $-0.03 | $-0.05 | $0.02 | $0.07 | $0.03 | $-0.06 | $0.06 | $-0.48 | $-0.45 | $-0.45 | $-1.14 | $-0.58 | $-0.77 | $-0.82 | $-0.96 | |
| Shares (Basic) | 35,891,915 | 36,021,210 | -70,991,574 | 36,383,277 | 35,786,813 | 34,642,641 | -53,478,825 | 28,738,307 | 28,364,731 | 24,887,180 | -25,719,196 | 17,863,078 | 12,463,665 | 11,622,384 | -16,732,137 | 9,215,786 | |
| Shares (Diluted) | 39,761,480 | 36,021,210 | -79,911,141 | 40,056,814 | 40,262,764 | 39,511,120 | -57,086,190 | 32,345,672 | 28,364,731 | 24,887,180 | -25,719,196 | 17,863,078 | 12,463,665 | 11,622,384 | -16,732,137 | 9,215,786 | |
| EBITDA | $2M | $-2M | · | $-388.0K | $3M | $642.0K | · | $-1M | $-4M | $-10M | · | $-11M | $-8M | $-8M | · | $-8M |
Bilan 23
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $48M | $41M | $43M | $42M | $34M | $13M | $32M | $8M | $15M | $12M | $13M | $40M | $15M | $24M | $8M | $10M | |
| Receivables | $16M | $14M | $12M | $14M | $16M | $14M | $11M | $7M | $4M | $2M | $241.0K | $205.0K | $127.0K | $458.0K | $366.0K | $537.0K | |
| Inventory | $12M | $10M | $10M | $11M | $11M | $7M | $7M | $7M | $6M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | |
| Prepaid Expense | $7M | $7M | $6M | $7M | $6M | $4M | $3M | $1M | $1M | $1M | $1M | $3M | $2M | $2M | $2M | $2M | |
| Current Assets | $131M | $120M | $120M | $121M | $113M | $84M | $74M | $29M | $31M | $34M | $37M | $46M | $19M | $29M | $16M | $18M | |
| PP&E (Net) | $4M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| PP&E (Gross) | $9M | $9M | $8M | $8M | $8M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | |
| Accum. Depreciation | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Total Assets | $137M | $125M | $124M | $124M | $117M | $87M | $77M | $32M | $34M | $36M | $39M | $48M | $21M | $31M | $18M | $20M | |
| Accounts Payable | $4M | $3M | $3M | $2M | $5M | $2M | $961.0K | $937.0K | $3M | $1M | $1M | $753.0K | $966.0K | $2M | $2M | $3M | |
| Accrued Liabilities | $9M | $7M | $8M | $6M | $6M | $4M | $5M | $6M | $4M | $4M | $5M | $5M | $6M | $7M | $5M | $5M | |
| Current Liabilities | $13M | $11M | $11M | $8M | $10M | $5M | $6M | $22M | $12M | $13M | $16M | $14M | $11M | $13M | $15M | $14M | |
| Capital Leases | $2M | $815.0K | $835.0K | $855.0K | $877.0K | $906.0K | $933.0K | $963.0K | $989.0K | $1M | $0 | · | · | · | · | · | |
| Other Non-current Liabilities | $327.0K | $615.0K | $628.0K | $582.0K | $578.0K | $896.0K | $766.0K | $563.0K | $632.0K | $962.0K | $840.0K | $1M | $1M | $1M | $1M | $1M | |
| Total Liabilities | $16M | $12M | $12M | $9M | $12M | $7M | $8M | $23M | $30M | $21M | $23M | $23M | $21M | $25M | $24M | $25M | |
| Long-term Debt | · | · | · | · | · | · | · | $2M | $4M | $7M | $10M | · | · | · | $16M | · | |
| Common Stock | $346.0K | $344.0K | $347.0K | $353.0K | $350.0K | $334.0K | $331.0K | $280.0K | $279.0K | $254.0K | $228.0K | $197.0K | $153.0K | $101.0K | $100.0K | $86.0K | |
| Paid-in Capital | $648M | $642M | $639M | $641M | $632M | $610M | $600M | $536M | $534M | $530M | $521M | $519M | $473M | $453M | $452M | $442M | |
| Retained Earnings | $-527M | $-530M | $-529M | $-527M | $-528M | $-530M | $-532M | $-528M | $-530M | $-516M | $-505M | $-494M | $-474M | $-466M | $-457M | $-447M | |
| AOCI | $258.0K | $571.0K | $575.0K | $875.0K | $592.0K | $381.0K | $82.0K | $11.0K | $8.0K | $157.0K | $135.0K | $-59.0K | $-64.0K | $-64.0K | $-83.0K | $-57.0K | |
| Stockholders' Equity | $121M | $113M | $111M | $115M | $105M | $80M | $69M | $9M | $4M | $15M | $16M | $25M | $-242.0K | $-13M | $-6M | $-5M | |
| Liabilities + Equity | $137M | $125M | $124M | $124M | $117M | $87M | $77M | $32M | $34M | $36M | $39M | $48M | $21M | $31M | $18M | $20M | |
| Shares Outstanding | 34,636,252 | 34,465,087 | 34,691,671 | 35,308,939 | 34,955,974 | 33,436,612 | 33,061,002 | 28,019,599 | 27,931,393 | 25,439,319 | 22,761,554 | 19,688,991 | 15,250,469 | 10,046,571 | 10,046,571 | 8,597,682 |
Flux de trésorerie 10
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $6M | $857.0K | $8M | $5M | $7M | $2M | $-1M | $-4M | $-4M | $-10M | $-8M | $-9M | $-10M | $-4M | $-7M | $-5M | |
| CapEx | $503.0K | $570.0K | $550.0K | $459.0K | $398.0K | $140.0K | $229.0K | $216.0K | $101.0K | $13.0K | $19.0K | $-1.0K | $40.0K | $0 | $0 | $68.0K | |
| Investing Cash Flow | $-504.0K | $-571.0K | $-561.0K | $-466.0K | $-415.0K | $-25M | $-15M | $-697.0K | $10M | $5M | $-20M | $1.0K | $-40.0K | $0 | $0 | $-68.0K | |
| Stock Issued | $0 | $389.0K | $0 | $243.0K | $0 | $238.0K | $0 | $175.0K | $0 | $75.0K | $0 | $76.0K | $0 | $47.0K | $0 | $0 | |
| Stock Repurchased | $11.0K | $3M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $-3M | · | · | · | $238.0K | · | · | · | $75.0K | · | · | · | $47.0K | · | · | |
| Financing Cash Flow | $962.0K | $-2M | $-6M | $3M | $15M | $3M | $40M | $-2M | $-3M | $4M | $1.0K | $35M | $7.0K | $17M | $5M | $5M | |
| Net Change in Cash | $6M | $-2M | $2M | $7M | $22M | $-20M | $24M | $-6M | $3M | $-886.0K | $-28M | $26M | $-10M | $12M | $-2M | $-372.0K | |
| Taxes Paid | · | · | $228.0K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $287.0K | · | · | · | $2M | · | · | · | $-10M | · | · | · | $-4M | · | · |
Rentabilité 8
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 89.8% | 85.0% | · | 87.2% | 86.3% | 85.6% | · | 85.4% | 80.4% | 71.2% | · | 69.3% | 69.7% | 69.7% | · | · | |
| Operating Margin | 8.2% | -6.6% | · | -1.9% | 10.7% | 3.2% | · | -11.2% | -50.4% | -327.4% | · | -2432.3% | -1615.6% | -1394.5% | · | · | |
| Net Margin | 9.2% | -4.3% | · | 4.0% | 11.2% | 5.4% | · | 16.6% | -176.9% | -354.0% | · | -4686.6% | -1455.0% | -1507.5% | · | · | |
| Pretax Margin | 10.8% | -3.6% | · | 1.8% | 13.3% | 6.4% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | 8.2% | -6.6% | · | -1.9% | 10.7% | 3.2% | · | -11.2% | -50.4% | -327.4% | · | -2432.3% | -1615.6% | -1394.5% | · | · | |
| ROA | 2.1% | -1.0% | · | 1.1% | 3.6% | 1.7% | · | 4.7% | -50.0% | -33.3% | · | -60.0% | -34.2% | -31.1% | · | -31.1% | |
| ROE | 2.4% | -1.1% | · | 1.4% | 4.9% | 2.2% | · | 11.2% | -695.8% | -1439.2% | · | -208.9% | 466.5% | 229.3% | · | -262.5% | |
| ROIC | 1.7% | -1.7% | · | -0.75% | 2.1% | 0.68% | · | · | · | · | · | · | · | · | · | · |
Liquidité et Solvabilité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.8 | 11.2 | · | 15.1 | 10.9 | 16.0 | · | 1.3 | 2.6 | 2.5 | · | 3.3 | 1.8 | 2.2 | · | 1.3 | |
| Quick Ratio | 4.8 | 5.2 | · | 6.9 | 4.8 | 5.1 | · | 0.7 | 1.5 | 1.0 | · | 2.9 | 1.3 | 1.8 | · | 0.7 |
Efficacité 3
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | · | |
| Inventory Turnover | 0.3 | 0.4 | · | 0.3 | 0.4 | 0.5 | · | 0.4 | 0.3 | 0.3 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.8 | 1.8 | · | 2.0 | 2.5 | 2.6 | · | 3.1 | 4.0 | 3.1 | · | 1.2 | 1.8 | 1.9 | · | · |
Valorisation (TTM) 10
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $99M | $89M | · | $76M | $63M | $42M | · | $23M | $12M | $5M | · | $2M | $3M | $3M | · | · | |
| Net Income TTM | $5M | $4M | · | $6M | $-8M | $-22M | · | $-43M | $-52M | $-48M | · | $-45M | $-35M | $-37M | · | $-35M | |
| Market Cap | $436M | $320M | · | $380M | $475M | $426M | · | $253M | $234M | $121M | · | $80M | $89M | $58M | · | $28M | |
| P/E | 96.8 | 103.1 | · | 59.7 | -42.5 | -15.2 | · | -4.5 | -3.2 | -1.6 | · | -1.2 | -1.6 | -1.4 | · | -0.8 | |
| P/S | 4.4 | 3.6 | · | 5.0 | 7.6 | 10.2 | · | 11.2 | 19.8 | 26.0 | · | 32.8 | 31.8 | 21.6 | · | · | |
| P/B | 3.6 | 2.8 | · | 3.3 | 4.5 | 5.3 | · | 29.5 | 55.8 | 8.3 | · | 3.2 | -367.4 | -4.4 | · | -5.2 | |
| P / Tangible Book | 3.6 | 2.8 | · | 3.3 | 4.5 | 5.3 | · | 29.5 | 55.8 | 8.3 | · | 3.2 | · | · | · | · | |
| P / Cash Flow | · | 373.2 | · | · | · | 193.2 | · | · | · | -12.7 | · | · | · | -13.5 | · | · | |
| P / FCF | · | 1114.4 | · | · | · | 206.3 | · | · | · | -12.6 | · | · | · | -13.5 | · | · | |
| Earnings Yield | 1.0% | 0.97% | · | 1.7% | -2.4% | -6.6% | · | -22.3% | -31.7% | -61.6% | · | -85.2% | -60.9% | -70.8% | · | -132.5% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $85M | $37M | $2M | $3M | $4M |
| Marge Brute % | 86.2% | 83.4% | 69.2% | 74.8% | — |
| Marge d'exploitation % | 0.77% | -33.4% | -1849.0% | -1245.0% | — |
| Résultat net | $3M | $-26M | $-48M | $-37M | $-26M |
| BPA dilué | $0.07 | $-0.93 | $-2.94 | $-4.12 | $-3.59 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio de liquidité | 10.9 | 12.0 | 2.3 | 1.1 | 5.2 |
| Ratio de liquidité réduite | 5.0 | 7.0 | 0.8 | 0.5 | 3.8 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $21M | $-19M | $-31M | $-25M | $-23M |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 140 déclarants · $188.2M total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 27 (0 vs T. préc.) | 17 (-3 vs T. préc.) | 40 (+6 vs T. préc.) | 30 (-7 vs T. préc.) | +1.7M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| Rosalind Advisors, Inc. | $41 551 898 | 3 300 389 | 22,08% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $15 375 500 | 1 221 247 | 8,17% | Actions |
| VANGUARD GROUP INC | $14 879 573 | 1 473 225 | 7,91% | Actions |
| Propel Bio Management, LLC | $10 971 681 | 871 460 | 5,83% | Actions |
| STATE STREET CORP | $8 552 135 | 679 280 | 4,55% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $7 923 535 | 629 139 | 4,21% | Actions |
| ALGERT GLOBAL LLC | $7 311 114 | 580 708 | 3,89% | Actions |
| MILLENNIUM MANAGEMENT LLC | $7 130 611 | 566 371 | 3,79% | Actions |
| Divisadero Street Capital Management, LP | $6 292 432 | 499 796 | 3,34% | Actions |
| ExodusPoint Capital Management, LP | $4 530 940 | 359 884 | 2,41% | Actions |
| Private Wealth Advisors, LLC | $3 913 765 | 310 863 | 2,08% | Actions |
| Simplify Asset Management Inc. | $3 333 454 | 264 770 | 1,77% | Actions |
| BlackRock, Inc. | $3 180 738 | 252 640 | 1,69% | Actions |
| ADAR1 Capital Management, LLC | $2 825 007 | 224 385 | 1,50% | Actions |
| DIMENSIONAL FUND ADVISORS LP | $2 570 450 | 204 166 | 1,37% | Actions |
| KENNEDY CAPITAL MANAGEMENT LLC | $2 570 160 | 204 143 | 1,37% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2 435 510 | 193 448 | 1,29% | Actions |
| Ikarian Capital, LLC | $2 337 548 | 185 667 | 1,24% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $2 290 159 | 181 903 | 1,22% | Actions |
| CIBC WORLD MARKET INC. | $2 054 789 | 163 208 | 1,09% | Actions |
| Caption Management, LLC | $1 894 795 | 150 500 | 1,01% | Option de vente |
| GOLDMAN SACHS GROUP INC | $1 885 353 | 149 750 | 1,00% | Actions |
| Lane Generational LLC | $1 884 257 | 149 663 | 1,00% | Actions |
| HSBC HOLDINGS PLC | $1 705 848 | 135 600 | 0,91% | Actions |
| Man Group plc | $1 617 752 | 128 495 | 0,86% | Actions |
| Cubist Systematic Strategies, LLC | $1 562 514 | 145 350 | 0,83% | Actions |
| Diametric Capital, LP | $1 546 568 | 122 841 | 0,82% | Actions |
| MORGAN STANLEY | $1 366 506 | 108 539 | 0,73% | Actions |
| BARCLAYS PLC | $1 354 243 | 107 565 | 0,72% | Actions |
| Caption Management, LLC | $1 259 000 | 100 000 | 0,67% | Option d'achat |
| Capital Advisors Wealth Management, LLC | $1 170 870 | 93 000 | 0,62% | Actions |
| Jefferies Financial Group Inc. | $1 057 308 | 83 980 | 0,56% | Actions |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1 050 824 | 83 465 | 0,56% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1 022 308 | 81 200 | 0,54% | Option d'achat |
| Stonepine Capital Management, LLC | $1 000 000 | 100 000 | 0,53% | Option d'achat |
| Caption Management, LLC | $978 243 | 77 700 | 0,52% | Actions |
| FOX RUN MANAGEMENT, L.L.C. | $776 526 | 61 678 | 0,41% | Actions |
| Quantbot Technologies LP | $749 860 | 59 560 | 0,40% | Actions |
| D. E. Shaw & Co., Inc. | $728 885 | 57 894 | 0,39% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $725 864 | 57 654 | 0,39% | Actions |
| Pale Fire Capital SE | $504 670 | 40 085 | 0,27% | Actions |
| BANK OF AMERICA CORP /DE/ | $493 931 | 39 232 | 0,26% | Actions |
| WOLVERINE TRADING, LLC | $479 600 | 44 000 | 0,25% | Option d'achat |
| RHUMBLINE ADVISERS | $458 822 | 36 444 | 0,24% | Actions |
| ALPS ADVISORS INC | $441 154 | 35 040 | 0,23% | Actions |
| EntryPoint Capital, LLC | $437 641 | 34 761 | 0,23% | Actions |
| SEI INVESTMENTS CO | $394 936 | 31 369 | 0,21% | Actions |
| AMERICAN CENTURY COMPANIES INC | $378 380 | 30 054 | 0,20% | Actions |
| Balyasny Asset Management L.P. | $358 412 | 28 468 | 0,19% | Actions |
| Leonteq Securities AG | $348 730 | 27 699 | 0,19% | Actions |
| CITADEL ADVISORS LLC | $334 894 | 26 600 | 0,18% | Option d'achat |
| BOOTHBAY FUND MANAGEMENT, LLC | $319 484 | 25 376 | 0,17% | Actions |
| Xcelsior Advisor Partners LLC | $318 527 | 25 300 | 0,17% | Actions |
| Palisades Investment Partners, LLC | $293 007 | 23 273 | 0,16% | Actions |
| WOLVERINE TRADING, LLC | $269 666 | 24 740 | 0,14% | Actions |
| ALLIANCEBERNSTEIN L.P. | $239 424 | 25 800 | 0,13% | Actions |
| MetLife Investment Management, LLC | $235 043 | 18 669 | 0,12% | Actions |
| Bank of New York Mellon Corp | $234 942 | 18 661 | 0,12% | Actions |
| WealthPlan Investment Management, LLC | $219 607 | 17 443 | 0,12% | Actions |
| NOMURA HOLDINGS INC | $210 530 | 16 722 | 0,11% | Actions |
| WOLVERINE TRADING, LLC | $209 280 | 19 200 | 0,11% | Option de vente |
| CITADEL ADVISORS LLC | $202 699 | 16 100 | 0,11% | Option de vente |
| CITADEL ADVISORS LLC | $189 391 | 15 043 | 0,10% | Actions |
| SkyOak Wealth, LLC | $188 850 | 15 000 | 0,10% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $188 850 | 15 000 | 0,10% | Option de vente |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $166 729 | 13 243 | 0,09% | Actions |
| TUDOR INVESTMENT CORP ET AL | $151 609 | 12 042 | 0,08% | Actions |
| LANARK FINANCIAL, INC. | $150 500 | 11 954 | 0,08% | Actions |
| CITIGROUP INC | $146 485 | 11 635 | 0,08% | Actions |
| Invesco Ltd. | $143 790 | 11 421 | 0,08% | Actions |
| MERCER GLOBAL ADVISORS INC /ADV | $140 744 | 11 179 | 0,07% | Actions |
| Nuveen, LLC | $138 754 | 11 021 | 0,07% | Actions |
| Vanguard Global Advisers, LLC | $133 869 | 10 633 | 0,07% | Actions |
| Schonfeld Strategic Advisors LLC | $131 136 | 10 416 | 0,07% | Actions |
| LPL Financial LLC | $128 859 | 10 235 | 0,07% | Actions |
| TWO SIGMA INVESTMENTS, LP | $126 580 | 10 054 | 0,07% | Actions |
| Police & Firemen's Retirement System of New Jersey | $110 729 | 8 795 | 0,06% | Actions |
| SHERBROOKE PARK ADVISERS LLC | $109 918 | 10 883 | 0,06% | Actions |
| Hunting Hill Global Capital, LLC | $104 716 | 11 284 | 0,06% | Actions |
| MARSHALL WACE, LLP | $84 177 | 6 686 | 0,04% | Actions |
| FMR LLC | $69 144 | 5 492 | 0,04% | Actions |
| Private Wealth Advisors, LLC | $62 950 | 5 000 | 0,03% | Option d'achat |
| NEW YORK STATE COMMON RETIREMENT FUND | $60 432 | 4 800 | 0,03% | Actions |
| OSAIC HOLDINGS, INC. | $60 254 | 4 786 | 0,03% | Actions |
| Point72 (DIFC) Ltd | $53 931 | 5 017 | 0,03% | Actions |
| NORTHERN TRUST CORP | $53 797 | 4 273 | 0,03% | Actions |
| Persistent Asset Partners Ltd | $52 954 | 4 206 | 0,03% | Actions |
| Arax Advisory Partners | $51 884 | 4 121 | 0,03% | Actions |
| IFP Advisors, Inc | $51 657 | 4 103 | 0,03% | Actions |
| Integrated Wealth Concepts LLC | $48 145 | 3 824 | 0,03% | Actions |
| Ameritas Investment Partners, Inc. | $38 714 | 3 075 | 0,02% | Actions |
| Legal & General Group Plc | $34 534 | 2 743 | 0,02% | Actions |
| CWM, LLC | $29 343 | 3 162 | 0,02% | Actions |
| Creative Planning | $17 777 | 1 412 | 0,01% | Actions |
| Tripletail Wealth Management, LLC | $16 632 | 1 260 | 0,01% | Actions |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $14 950 | 1 611 | 0,01% | Actions |
| AlphaQuest LLC | $14 473 | 1 433 | 0,01% | Actions |
| Tower Research Capital LLC (TRC) | $13 711 | 1 089 | 0,01% | Actions |
| Activest Wealth Management | $12 590 | 1 000 | 0,01% | Actions |
| Geneos Wealth Management Inc. | $11 621 | 923 | 0,01% | Actions |
Initiés de la société 46 initiés · 11 dirigeants · 16 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Jennifer K. Simpson | President and CEO | 8 mai 2020 C | 25 021 | 0 | 0 | $0 |
| Barbra Keck | Chief Financial Officer, Secretary | 8 mai 2020 C | 12 851 | 0 | 0 | $0 |
| Paul M Feinstein | Chief Financial Officer | 30 novembre 2007 A | 3 375 | 0 | 0 | $0 |
| John Purpura | Chief Operating Officer | 13 octobre 2023 P | 41 526 | 0 | 0 | $0 |
| HERSCHKOWITZ SAMUEL /FA/ | Chief Operating Officer | 29 mai 2007 P | 160 375 | 0 | 0 | $0 |
| Vojo Vukovic | Chief Medical Officer | 12 décembre 2023 P | 100 000 | 0 | 0 | $0 |
| Sandra Pennell | SVP of Finance, PFO and PAO | 17 novembre 2023 P | 30 000 | 0 | 0 | $0 |
| David L. Hoffman | General Counsel, Chief Compliance Officer and Secretary | 16 novembre 2023 P | 40 000 | 0 | 0 | $0 |
| Kevin Muir | Vice President Commercial Operations | 12 juin 2023 A | — | 0 | 0 | $0 |
| Johnny John | Senior Vice President Clinical Development and Medical Affairs | 12 juin 2023 A | — | 0 | 0 | $0 |
| Christine Padula | Interim Principal Accounting Officer | 1 septembre 2021 A | — | 0 | 0 | $0 |
| John Richard Sylvester | Administrateur | 21 août 2023 P | 10 550 | 0 | 0 | $0 |
| Aharon Gil | Administrateur | 12 juin 2023 A | 404 000 | 0 | 0 | $0 |
| Steven A J Salamon | Administrateur | 12 juin 2023 A | 440 100 | 0 | 0 | $0 |
| Roger G Stoll PHD | Administrateur | 12 juin 2023 A | 9 309 | 0 | 0 | $0 |
| Rosalind Advisors, Inc. | Administrateur | 19 avril 2022 P | 433 100 | 0 | 0 | $0 |
| Marco Taglietti | Administrateur | 8 mai 2020 C | 6 000 | 0 | 0 | $0 |
| William Dodge Rueckert | Administrateur | 8 mai 2020 C | 6 014 | 0 | 0 | $0 |
| Simon Pedder | Administrateur | 1 février 2019 A | — | 0 | 0 | $0 |
| Laura A Philips | Administrateur | 23 juillet 2015 P | 205 299 | 0 | 0 | $0 |
| Harold S Koplewicz | Administrateur | 10 juin 2015 A | 45 052 | 0 | 0 | $0 |
| Dennis Langer | Administrateur | 10 juin 2015 A | 20 000 | 0 | 0 | $0 |
| Jonathan Lewis | Administrateur | 30 juin 2008 A | 10 000 | 0 | 0 | $0 |
| Mark Corigliano | Administrateur | 16 avril 2007 M | 198 176 | 0 | 0 | $0 |
| Daniel Isdaner | Administrateur | 16 avril 2007 M | 253 668 | 0 | 0 | $0 |
| Elizabeth Czerepak | — | 13 mai 2026 A | — | 0 | 0 | $0 |
| Gerard J Michel | — | 2 mars 2026 P | 342 034 | 2 | 0 | $198 447 |
| Laura Brege | — | 7 juillet 2014 A | 11 678 | 0 | 0 | $0 |
| Tasos Konidaris | — | 7 juillet 2014 A | 11 678 | 0 | 0 | $0 |
| Gabriel Leung | — | 7 juillet 2014 A | 21 485 | 0 | 0 | $0 |
| Douglas G Watson | — | 7 juillet 2014 A | 136 664 | 0 | 0 | $0 |
| Graham G Miao | — | 14 novembre 2013 A | 54 000 | 0 | 0 | $0 |
| Peter J Graham | — | 14 novembre 2013 A | 15 000 | 0 | 0 | $0 |
| William M Appling | — | 15 juillet 2013 A | — | 0 | 0 | $0 |
| Krishna Kandarpa | — | 11 mars 2013 A | 159 000 | 0 | 0 | $0 |
| Harold Mapes | — | 11 mars 2013 A | 17 000 | 0 | 0 | $0 |
| Eamonn P Hobbs | — | 11 mars 2013 A | 162 000 | 0 | 0 | $0 |
| Agustin V Gago | — | 11 mars 2013 A | 80 944 | 0 | 0 | $0 |
| Robert Ladd | — | 15 juin 2012 A | 69 534 | 0 | 0 | $0 |
| David Mcdonald | — | 10 mars 2011 A | 47 706 | 0 | 0 | $0 |
| Pamela Reilly Contag | — | 1 décembre 2010 A | 8 507 | 0 | 0 | $0 |
| Richard Taney | — | 10 décembre 2009 A | 211 485 | 0 | 0 | $0 |
| Jason Andrew Rifkin | — | 12 octobre 2009 A | — | 0 | 0 | $0 |
| KOLY M S /FA/ | — | 26 janvier 2007 X | 775 360 | 0 | 0 | $0 |
| Victor Nevins | — | 12 octobre 2006 M | 180 007 | 0 | 0 | $0 |
| VENKOL TRUST | — | 10 novembre 2004 J | 892 649 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 17 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| Rosalind Advisors, Inc., SALAMON STEVEN A J, Aharon Gil, Rosalind Master Fund L.P., Rosalind Opportunities Fund I L.P. ×15 dépôts | 10 février 2026 | 9,90% | Amendement | — | SEC |
| Personne déclarante non divulguée | 16 décembre 2022 | — | Dépôt initial | — | SEC |
| Personne déclarante non divulguée | 27 juillet 2022 | — | Dépôt initial | — | SEC |
| Laddcap Value Partners LP S.S. or, Laddcap Value Associates LLC S.S. or, Laddcap Value Advisors LLC S.S. or, Robert Ladd S.S. or ×2 dépôts | 2 août 2010 | — | Dépôt initial | — | SEC |
| Robert Ladd | 18 octobre 2006 | — | Dépôt initial | — | SEC |
| Personne déclarante non divulguée | 28 juillet 2006 | — | Dépôt initial | Campagne de conseil d'administration | SEC |
| Personne déclarante non divulguée | 11 juillet 2006 | — | Dépôt initial | — | SEC |
| Personne déclarante non divulguée | 14 juin 2006 | — | Dépôt initial | — | SEC |
| Personne déclarante non divulguée | 8 juin 2006 | — | Dépôt initial | — | SEC |
| Personne déclarante non divulguée | 24 mai 2006 | — | Dépôt initial | — | SEC |
| Personne déclarante non divulguée | 28 avril 2006 | — | Dépôt initial | — | SEC |
| Personne déclarante non divulguée | 10 janvier 2006 | — | Dépôt initial | — | SEC |
| Personne déclarante non divulguée | 6 janvier 2006 | — | Dépôt initial | — | SEC |
| Personne déclarante non divulguée | 14 décembre 2005 | — | Dépôt initial | — | SEC |
| Personne déclarante non divulguée | 10 novembre 2005 | — | Dépôt initial | Campagne de conseil d'administration | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 22 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 0,24% | 35 814 NS | 31 mai 2026 | N-PORT |
| IWC · iShares Trust | 0,10% | 97 850 SH | 8 août 2026 | Quotidien |
| GSSC · Goldman Sachs ETF Trust | 0,04% | 35 321 NS | 31 mai 2026 | N-PORT |
| IWN · iShares Trust | 0,02% | 227 534 SH | 8 août 2026 | Quotidien |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 21 358 SH | 8 août 2026 | Quotidien |
| IWM · iShares Trust | 0,01% | 741 852 SH | 8 août 2026 | Quotidien |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,01% | 2 388 SH | 8 août 2026 | Quotidien |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 165 177 SH | 8 août 2026 | Quotidien |
| RSSL · Global X Funds | 0,01% | 13 080 NS | 30 avril 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,01% | 22 609 NS | 31 mai 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 1 420 NS | 31 mai 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 1 111 NS | 31 mai 2026 | N-PORT |
| IWO · iShares Trust | 0,00% | 38 572 SH | 8 août 2026 | Quotidien |
| URTY · ProShares Trust | 0,00% | 1 122 NS | 31 mai 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 1 638 NS | 31 mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 28 NS | 31 mai 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 19 222 NS | 30 avril 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 43 750 SH | 8 août 2026 | Quotidien |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 304 809 SH | 8 août 2026 | Quotidien |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 889 410 SH | 8 août 2026 | Quotidien |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4 438 SH | 8 août 2026 | Quotidien |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2 475 SH | 8 août 2026 | Quotidien |